(Total Views: 123)
Posted On: 07/17/2025 1:03:47 AM
Post# of 8485
Viant Medical and VLMS Global Healthcare can benefit from BioElectronics Corporation (BIEL) being a public traded company—especially in light of ActiPatch’s recent global traction:
???? Global Adoption of ActiPatch Strengthens the Alliance
✅ Taiwan: Clinical Integration in 14 Hospitals
ActiPatch is now used at National Taiwan University Hospital and approved in 13 other hospitals, including Taipei Tzu Chi, Mackay Medical Center, and National Army Beitou.
This clinical adoption validates ActiPatch’s efficacy and opens doors for insurance reimbursement and hospital procurement—a direct win for VLMS’s coding and billing services.
???????? South Africa: Nationwide Retail & Clinical Access
ActiPatch is available through major pharmacies and online platforms like Mopani, Cura Pharm, and Bizzmed35.
Distributed by Adcock Ingram, a leading pharmaceutical company, enhancing credibility and reach.
VLMS can tap into South Africa’s chronic pain prevalence (1 in 5 adults) for reimbursement coding, while Viant benefits from increased device demand.
???????? New Zealand: Official Launch & Distribution
ActiPatch is now sold via ActiPatch.nz and distributed by TOP Medical NZ.
Positioned as a drug-free, prescription-free solution for arthritis, fibromyalgia, and sports injuries.
Viant’s manufacturing scales with demand; VLMS can expand reimbursement pathways via New Zealand’s public health system.
???? How BIEL’s Public Status Amplifies These Wins
1. Capital Access for Global Expansion
BIEL can raise public funds to support:
Viant’s production scale-up for international orders.
VLMS’s backend infrastructure for global reimbursement coding.
2. Credibility with Hospitals & Retailers
Public status boosts trust with:
Hospital systems in Taiwan and South Africa.
Retail chains like Walgreens, CVS, and now international outlets.
3. Revenue Growth Shared Across Partners
Region Adoption Type Partner Benefit
Taiwan Hospital integration VLMS: coding & billing; Viant: device demand
South Africa Retail & clinical VLMS: reimbursement; Viant: manufacturing
New Zealand Direct-to-consumer VLMS: backend analytics; Viant: app/device
???? Strategic Synergy: Smart Relief Alliance
Viant Medical: Builds the connected wearable and app interface.
VLMS Healthcare: Handles reimbursement, analytics, and payer engagement.
BIEL: Provides FDA-cleared technology and public funding leverage.
Together, they’re creating a smart, reimbursable, AI-powered pain therapy ecosystem—just as global demand for non-opioid solutions surges.
???? Global Adoption of ActiPatch Strengthens the Alliance
✅ Taiwan: Clinical Integration in 14 Hospitals
ActiPatch is now used at National Taiwan University Hospital and approved in 13 other hospitals, including Taipei Tzu Chi, Mackay Medical Center, and National Army Beitou.
This clinical adoption validates ActiPatch’s efficacy and opens doors for insurance reimbursement and hospital procurement—a direct win for VLMS’s coding and billing services.
???????? South Africa: Nationwide Retail & Clinical Access
ActiPatch is available through major pharmacies and online platforms like Mopani, Cura Pharm, and Bizzmed35.
Distributed by Adcock Ingram, a leading pharmaceutical company, enhancing credibility and reach.
VLMS can tap into South Africa’s chronic pain prevalence (1 in 5 adults) for reimbursement coding, while Viant benefits from increased device demand.
???????? New Zealand: Official Launch & Distribution
ActiPatch is now sold via ActiPatch.nz and distributed by TOP Medical NZ.
Positioned as a drug-free, prescription-free solution for arthritis, fibromyalgia, and sports injuries.
Viant’s manufacturing scales with demand; VLMS can expand reimbursement pathways via New Zealand’s public health system.
???? How BIEL’s Public Status Amplifies These Wins
1. Capital Access for Global Expansion
BIEL can raise public funds to support:
Viant’s production scale-up for international orders.
VLMS’s backend infrastructure for global reimbursement coding.
2. Credibility with Hospitals & Retailers
Public status boosts trust with:
Hospital systems in Taiwan and South Africa.
Retail chains like Walgreens, CVS, and now international outlets.
3. Revenue Growth Shared Across Partners
Region Adoption Type Partner Benefit
Taiwan Hospital integration VLMS: coding & billing; Viant: device demand
South Africa Retail & clinical VLMS: reimbursement; Viant: manufacturing
New Zealand Direct-to-consumer VLMS: backend analytics; Viant: app/device
???? Strategic Synergy: Smart Relief Alliance
Viant Medical: Builds the connected wearable and app interface.
VLMS Healthcare: Handles reimbursement, analytics, and payer engagement.
BIEL: Provides FDA-cleared technology and public funding leverage.
Together, they’re creating a smart, reimbursable, AI-powered pain therapy ecosystem—just as global demand for non-opioid solutions surges.
(1)
(0)
